| Medical and Health Sciences | Lifetime | 143 | US 79 | 99.99 |
| Medical and Health Sciences | 2021-2025 | 558 | US 193 | 99.88 |
| Nephrology | Lifetime | 7 | US 5 | 99.97 |
| Medical Physiology | Lifetime | 430 | US 235 | 99.31 |
| Hematology | Lifetime | 161 | US 86 | 99.08 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 508 | US 275 | 98.45 |
| Pulmonary and Respiratory Medicine | Lifetime | 920 | US 475 | 98.49 |
| Emergency Medical Services | Lifetime | 313 | US 151 | 97.07 |
| Transplantation | Lifetime | 290 | US 134 | 90.41 |
| Speech and Hearing | Lifetime | 794 | US 347 | 79.82 |
| Nephrology | 2021-2025 | 18 | US 8 | 99.61 |
| Medical Physiology | 2021-2025 | 300 | US 103 | 95.93 |
| General Health Professions | 2021-2025 | 750 | US 259 | 93.86 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 269 | US 111 | 94.05 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 603 | US 209 | 92.98 |
| Iron Metabolism and Disorders | Lifetime | 2 | US 2 | 99.90 |
| Dialysis and Renal Disease Management | Lifetime | 3 | US 3 | 99.97 |
| Muscle and Compartmental Disorders | Lifetime | 1 | US 1 | 99.96 |
| Parathyroid Disorders and Treatments | Lifetime | 3 | US 3 | 99.88 |
| Central Venous Catheters and Hemodialysis | Lifetime | 11 | US 8 | 99.76 |
| Nutrition and Health in Aging | Lifetime | 20 | US 13 | 99.88 |
| Chronic Kidney Disease and Diabetes | Lifetime | 12 | US 9 | 99.83 |
| Erythropoietin and Anemia Treatment | Lifetime | 5 | US 3 | 99.79 |
| Folate and B Vitamins Research | Lifetime | 26 | US 15 | 99.33 |
| Neurological and metabolic disorders | Lifetime | 12 | US 5 | 99.57 |
| Potassium and Related Disorders | Lifetime | 11 | US 8 | 99.75 |
| Renal function and acid-base balance | Lifetime | 24 | US 14 | 99.32 |
| Electrolyte and hormonal disorders | Lifetime | 36 | US 19 | 99.28 |
| Hemoglobinopathies and Related Disorders | Lifetime | 141 | US 72 | 98.77 |
| Vitamin D Research Studies | Lifetime | 98 | US 46 | 98.98 |
| Pharmacological Effects and Toxicity Studies | Lifetime | 158 | US 65 | 98.99 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 379 | US 184 | 98.95 |
| Acute Kidney Injury Research | Lifetime | 99 | US 47 | 98.60 |
| Renal Transplantation Outcomes and Treatments | Lifetime | 281 | US 148 | 98.73 |
| Diet and metabolism studies | Lifetime | 773 | US 334 | 98.66 |
| Healthcare cost, quality, practices | Lifetime | 124 | US 75 | 97.99 |
| Diabetes Treatment and Management | Lifetime | 466 | US 178 | 98.27 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 192 | US 37 | 95.57 |
| Body Composition Measurement Techniques | Lifetime | 204 | US 80 | 97.90 |
| Renal and Vascular Pathologies | Lifetime | 410 | US 231 | 97.57 |
| Magnesium in Health and Disease | Lifetime | 82 | US 38 | 97.37 |
| Diabetes Management and Research | Lifetime | 628 | US 278 | 97.96 |
| Heart Failure Treatment and Management | Lifetime | 628 | US 298 | 97.74 |
| Blood Pressure and Hypertension Studies | Lifetime | 853 | US 351 | 97.74 |
| Organ Donation and Transplantation | Lifetime | 616 | US 315 | 95.94 |
| Clinical Nutrition and Gastroenterology | Lifetime | 782 | US 318 | 95.19 |
| HIV-related health complications and treatments | Lifetime | 589 | US 323 | 95.79 |
| GDF15 and Related Biomarkers | Lifetime | 200 | US 69 | 90.32 |
| Alkaline Phosphatase Research Studies | Lifetime | 689 | US 279 | 80.79 |
| Restless Legs Syndrome Research | Lifetime | 962 | US 278 | 79.85 |
| Dialysis and Renal Disease Management | 2021-2025 | 11 | US 4 | 99.62 |
| Renal function and acid-base balance | 2021-2025 | 6 | US 2 | 97.01 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 61 | US 24 | 98.32 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 266 | US 87 | 97.26 |
| Parathyroid Disorders and Treatments | 2021-2025 | 59 | US 20 | 97.23 |
| Diet and metabolism studies | 2021-2025 | 375 | US 113 | 96.22 |
| Magnesium in Health and Disease | 2021-2025 | 14 | US 2 | 94.95 |
| Electrolyte and hormonal disorders | 2021-2025 | 55 | US 19 | 93.89 |
| Potassium and Related Disorders | 2021-2025 | 44 | US 23 | 96.31 |
| Healthcare cost, quality, practices | 2021-2025 | 119 | US 56 | 91.83 |
| Central Venous Catheters and Hemodialysis | 2021-2025 | 191 | US 59 | 91.95 |
| Nutrition and Health in Aging | 2021-2025 | 819 | US 113 | 92.35 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 72 | US 26 | 92.54 |
| Muscle and Compartmental Disorders | 2021-2025 | 60 | US 10 | 89.06 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 481 | US 136 | 91.79 |
| Renal and Vascular Pathologies | 2021-2025 | 271 | US 85 | 88.81 |
| Iron Metabolism and Disorders | 2021-2025 | 428 | US 157 | 88.28 |
| Organ Donation and Transplantation | 2021-2025 | 393 | US 170 | 87.83 |
| Protein Degradation and Inhibitors | 2021-2025 | 813 | US 341 | 86.17 |
| Acute Kidney Injury Research | 2021-2025 | 570 | US 163 | 82.53 |
| Health Literacy and Information Accessibility | 2021-2025 | 626 | US 141 | 73.16 |
| Social Media in Health Education | 2021-2025 | 704 | US 319 | 64.61 |
| Neurological and metabolic disorders | 2021-2025 | 366 | US 78 | 60.60 |
| Sodium Intake and Health | 2021-2025 | 888 | US 193 | 59.19 |
| Ion Transport and Channel Regulation | 2021-2025 | 601 | US 184 | 58.65 |
| Restless Legs Syndrome Research | 2021-2025 | 693 | US 132 | 49.96 |